Explore how MRI imaging acts as a pivotal scientific hub, bridging the gap between preclinical and clinical research to drive ...
The dire circumstances facing cystic fibrosis patients in Cuba have come to light through a heartfelt letter sent to our news ...
modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 for wet AMD and DME and 4D-710 for cystic fibrosis ...
Ivacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis treatment in patients ...
Lupin Ltd. signed a share subscription & shareholders agreement with Sunsure Solarpark Seventeen Pvt. and Sunsure Energy Pvt. to acquire equity investment up to 42.61% of equity share capital of ...
A new treatment for cystic fibrosis has been approved by the U.S. Food and Drug Administration (FDA).
These generic granules are equivalent to Vertex Pharmaceuticals' 'Kalydeco' oral granules in the same strengths.
These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...
India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback